Caris Life Sciences (CAI) Financials: History & Chart

Caris Life Sciences, Inc.(CAI)

Biotechnology · Irving, TX

$30.39+2.09 (+7.39%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Caris Life Sciences, Inc.

Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.

Irving, TX

1,846 employees

www.carislifesciences.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: David Dean Halbert

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	989.61M	263.71M	216.17M	292.89M	216.83M	181.40M	120.92M	129.91M	101.62M
Cost of Goods Sold	300.24M	84.12M	74.83M	71.97M	69.33M	67.71M	63.85M	59.21M	57.21M
Gross Profit	689.36M	179.60M	141.35M	220.91M	147.51M	113.69M	57.06M	70.70M	44.41M
Gross Profit Margin	69.7%	68.1%	65.4%	75.4%	68.0%	62.7%	47.2%	54.4%	43.7%
Total Operating Expenses	536.10M	152.67M	136.07M	132.50M	114.86M	95.70M	115.02M	107.75M	105.25M
Research & Development	91.20M	32.36M	5.37M	31.84M	21.62M	25.05M	23.07M	27.11M	27.64M
Selling, General & Administrative	418.96M	120.31M	104.75M	100.66M	93.24M	106.63M	91.95M	80.64M	77.61M
Operating Income (EBIT)	153.26M	26.93M	5.28M	88.41M	32.64M	17.99M	-57.95M	-37.05M	-60.84M
Operating Margin	15.5%	10.2%	2.4%	30.2%	15.1%	9.9%	-47.9%	-28.5%	-59.9%
Income Before Tax (EBT)	105.02M	-614K	-644K	81.96M	24.32M	-71.79M	-102.58M	-36.95M	-67.73M
Interest Income	28.03M	6.82M	6.83M	7.01M	7.36M	1.62M	503K	970K	1.74M
Interest Expense	46.90M	9.23M	12.81M	11.36M	13.51M	19.21M	12.78M	13.26M	13.80M
Other Income/Expense	-48.24M	-27.54M	-5.93M	-6.45M	-8.32M	-89.78M	-44.63M	99K	-6.89M
Net Income	105.14M	-637K	-510K	81.96M	24.32M	-71.79M	-102.58M	-36.95M	-67.73M
Income Tax Expense	-111K	23K	-134K	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit Margin	10.6%	-0.2%	-0.2%	28.0%	11.2%	-39.6%	-84.8%	-28.4%	-66.6%
EBITDA	174.03M	33.46M	10.35M	92.70M	37.51M	24.40M	-50.91M	-27.98M	-50.31M
EBITDA Margin	17.6%	12.7%	4.8%	31.7%	17.3%	13.4%	-42.1%	-21.5%	-49.5%
Depreciation & Amortization	20.76M	6.54M	5.07M	4.29M	4.87M	6.41M	7.04M	9.07M	10.53M
EPS Basic	0.37	-0.00	-0.00	0.29	0.09	N/A	-0.40	-0.22	-0.33
EPS Diluted	0.36	-0.00	-0.00	0.28	0.08	N/A	-0.40	-0.22	-0.33
Weighted Average Basic Shares	282.89M	282.89M	282.56M	282.33M	282.10M	268.44M	254.79M	281.09M	281.09M
Weighted Average Diluted Shares	282.89M	282.89M	282.56M	289.89M	297.21M	276.00M	254.79M	281.09M	281.09M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Revenue	812.03M	412.26M	306.13M	258.49M	294.01M	416.54M	432.10M	348.39M
Cost of Goods Sold	272.87M	233.48M	216.82M	178.46M	109.86M	216.03M	218.47M	179.11M
Gross Profit	539.17M	178.78M	89.31M	80.02M	184.16M	200.51M	213.63M	169.29M
Gross Profit Margin	66.4%	43.4%	29.2%	31.0%	62.6%	48.1%	49.4%	48.6%
Total Operating Expenses	494.06M	435.90M	408.86M	395.78M	45.07M	70.23M	64.85M	63.62M
Research & Development	45.31M	113.92M	116.88M	101.27M	N/A	N/A	N/A	N/A
Selling, General & Administrative	392.47M	321.86M	291.48M	294.51M	27.31M	52.70M	50.30M	42.70M
Operating Income (EBIT)	45.11M	-257.12M	-319.55M	-315.76M	139.09M	130.28M	148.78M	105.67M
Operating Margin	5.6%	-62.4%	-104.4%	-122.2%	47.3%	31.3%	34.4%	30.3%
Income Before Tax (EBT)	-68.09M	-281.89M	-341.42M	-320.83M	29.53M	55.21M	81.48M	57.20M
Interest Income	16.50M	7.12M	11.26M	947K	N/A	N/A	N/A	N/A
Interest Expense	56.85M	50.02M	31.61M	26.68M	61.56M	79.16M	78.34M	53.05M
Other Income/Expense	-113.20M	-24.77M	-21.86M	-5.07M	-109.55M	0.00	-67.30M	-48.47M
Net Income	-537.96M	-281.89M	-341.42M	-320.83M	27.73M	31.01M	78.60M	72.06M
Income Tax Expense	469.87M	0.00	0.00	0.00	1.80M	4.19M	2.89M	-14.86M
Net Profit Margin	-66.2%	-68.4%	-111.5%	-124.1%	9.4%	7.4%	18.2%	20.7%
EBITDA	67.73M	-208.21M	-270.55M	-267.50M	249.74M	244.21M	272.26M	218.93M
EBITDA Margin	8.3%	-50.5%	-88.4%	-103.5%	84.9%	58.6%	63.0%	62.8%
Depreciation & Amortization	22.61M	48.91M	49.00M	48.25M	110.65M	113.93M	123.48M	113.26M
EPS Basic	-1.91	N/A	-1.82	-1.57	1.55	1.72	3.97	3.74
EPS Diluted	-1.86	N/A	-1.82	-1.57	1.55	1.72	3.97	3.68
Weighted Average Basic Shares	282.33M	254.66M	254.66M	254.79M	17.95M	18.01M	19.82M	19.25M
Weighted Average Diluted Shares	289.89M	254.66M	254.66M	254.79M	17.95M	18.01M	19.82M	19.61M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.